staurosporine aglycone has been researched along with Glioblastoma in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singer, HS | 1 |
| Hansen, B | 1 |
| Martinie, D | 1 |
| Karp, CL | 1 |
1 other study available for staurosporine aglycone and Glioblastoma
| Article | Year |
|---|---|
Mitogenesis in glioblastoma multiforme cell lines: a role for NGF and its TrkA receptors.
Topics: Carbazoles; Cell Division; Enzyme Inhibitors; Glioblastoma; Humans; Indole Alkaloids; Mitosis; Nerve | 1999 |